Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)
| Market Cap | 1.65B +15.1% |
| Revenue (ttm) | 6.10B +15.2% |
| Net Income | 148.50M +31.6% |
| EPS | 0.99 +30.8% |
| Shares Out | 149.38M |
| PE Ratio | 11.19 |
| Forward PE | 7.71 |
| Dividend | 0.25 (2.28%) |
| Ex-Dividend Date | Sep 25, 2026 |
| Volume | 442,800 |
| Open | 10.99 |
| Previous Close | 11.00 |
| Day's Range | 10.91 - 11.19 |
| 52-Week Range | 9.01 - 16.57 |
| Beta | 0.37 |
| Analysts | Strong Buy |
| Price Target | 17.50 (+58.51%) |
| Est. Earnings | Mar 19, 2027 |
About BVMF:PNVL3
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil. [Read more]
Financial Performance
In 2025, BVMF:PNVL3's revenue was 5.51 billion, an increase of 11.53% compared to the previous year's 4.94 billion. Earnings were 124.61 million, an increase of 18.10%.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for PNVL3 stock is "Strong Buy." The 12-month stock price target is R$17.50, which is an increase of 58.51% from the latest price.
News
Dimed S.A. Distribuidora de Medicamentos Earnings Call Transcript: Q3 2026
Q3 sales grew 15.3%, EBITDA rose more than 21% and net profit increased more than 35%, alongside positive free cash flow and lower leverage. Digital channels accounted for almost 47% of retail sales, and management expects two-digit Q4 sales growth.
Dimed S.A. Distribuidora de Medicamentos Slides: Q3 2026
Dimed S.A. Distribuidora de Medicamentos has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 6, 2026.
Dimed S.A. Distribuidora de Medicamentos Earnings release: Q3 2026
Dimed S.A. Distribuidora de Medicamentos released its Q3 2026 earnings on November 6, 2026, summarizing the period's financial results.
Dimed S.A. Distribuidora de Medicamentos Quarterly report: Q3 2026
Dimed S.A. Distribuidora de Medicamentos has published its Q3 2026 quarterly earnings report on November 6, 2026.
Dimed S.A. Distribuidora de Medicamentos Earnings Call Transcript: Q2 2026
Q2 sales rose 15.8%, mature-store sales grew 11.4%, and market share reached 13.5%. EBITDA and net income advanced while gross margin eased; continued cash generation and deleveraging support 2030 growth and margin targets.
Dimed S.A. Distribuidora de Medicamentos Earnings release: Q2 2026
Dimed S.A. Distribuidora de Medicamentos released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
Dimed S.A. Distribuidora de Medicamentos Quarterly report: Q2 2026
Dimed S.A. Distribuidora de Medicamentos has published its Q2 2026 quarterly earnings report on August 7, 2026.
Dimed S.A. Distribuidora de Medicamentos Slides: Q2 2026
Dimed S.A. Distribuidora de Medicamentos has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 7, 2026.
Dimed S.A. Distribuidora de Medicamentos Slides: Q1 2026
Dimed S.A. Distribuidora de Medicamentos has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on June 4, 2026.
Dimed S.A. Distribuidora de Medicamentos Quarterly report: Q1 2026
Dimed S.A. Distribuidora de Medicamentos has published its Q1 2026 quarterly earnings report on June 4, 2026.
Dimed S.A. Distribuidora de Medicamentos Earnings release: Q1 2026
Dimed S.A. Distribuidora de Medicamentos released its Q1 2026 earnings on June 4, 2026, summarizing the period's financial results.
Dimed S.A. Distribuidora de Medicamentos Earnings Call Transcript: Q4 2025
Sales grew 17% in 2025, with digital and own-brand products driving revenue and margin gains. GLP-1 drugs now represent 11% of sales, with generics expected to boost growth and margins in 2026. Strong cash flow, improved leverage, and a clear path to double revenue by 2030.
Dimed S.A. Distribuidora de Medicamentos Earnings release: Q4 2025
Dimed S.A. Distribuidora de Medicamentos released its Q4 2025 earnings on March 20, 2026, summarizing the period's financial results.
Dimed S.A. Distribuidora de Medicamentos Annual report: Q4 2025
Dimed S.A. Distribuidora de Medicamentos has published its Q4 2025 annual report on March 20, 2026.
Dimed S.A. Distribuidora de Medicamentos Slides: Q4 2025
Dimed S.A. Distribuidora de Medicamentos has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 20, 2026.
Dimed S.A. Distribuidora de Medicamentos Slides: Investor presentation
Dimed S.A. Distribuidora de Medicamentos has posted slides in relation to its latest quarterly earnings report, which was published on February 26, 2026.